Hints and tips:
Related Special Reports
...The R-word now hanging around Rishi Sunak, which she was quick to exploit....
...Ziyad Al-Aly, R&D chief at Veterans Affairs St Louis Health Care System and clinical epidemiologist at Washington University in St Louis, discovered that patients in the VA’s extensive database who had recovered...
...McGoogan reports that the former headmaster at Treloar’s, Alec Macpherson, was asked at the infected blood inquiry if the school should have exercised greater oversight....
...Data visualisation by Alan Smith and Keith Fray Letters in response to this article: Forcing states to take sides only leads to frustration / From Daniel R DePetris, Fellow, Defense Priorities, New Rochelle...
...Even so, Tate & Lyle has refocused its investment and R&D on stevia in response to client demand....
...Ramaphosa has identified a retired judge to head the Lady R inquiry but has yet to name that person or finalise the terms of reference for the probe, his office said this week....
...A member of Jagex’s marketing team, Alec Sween (aka Mod[erator] Sween), said last September that Jagex was banning 200,000 bots per month....
...“The CEO is understandably impatient for success but the nature of pharma R&D means it takes a long time to turn such a business around, particularly given the paucity of the legacy she inherited,” the shareholder...
...A vaccine that offers global protection would also be cheaper, and less demanding of overburdened health systems, Saville adds, pointing to the huge R&D costs of updating and rolling out a vaccine against...
...Reporting team: Peter Foster, Delphine Strauss, Bethan Staton, Clive Cookson, George Hammond, Harry Dempsey and Sarah Neville. Cartography by Liz Faunce...
...in the Lords / From Dr Stuart R Gould, London N6, UK...
...FT Reporters: Peter Foster, Sarah Neville, Bethan Staton, Jane Croft, Sebastian Payne, Laura Hughes, Mure Dickie, Helen Warrell, Clive Cookson, Philip Georgiadis, Judith Evans, Robert Wright....
...The reproduction rate, or R value, of Covid-19 had risen to between 1.2 and 1.5, up slightly from between 1.1 and 1.3 the week before, according to the Government Office for Science....
...Alec Russell is the editor of FTWeekend Follow @FTLifeArts on Twitter to find out about our latest stories first...
...“When she first came in, she hired some very good people around her, the ex-HSBC chief financial officer, a new head of pharma, a new head of R&D....
...sarah.neville@ft.com...
...The biotech’s own R&D has taken a back seat since 2013, when it struck a lucrative contract with Novartis to manufacture the Swiss pharma group’s breakthrough gene therapy for blood cancer, Kymriah....
...In northern England, where R is between 0.9 and 1.1, the infection rate was holding steady....
...Mene Pangalos, head of Biopharmaceuticals R&D for AstraZeneca, said the company was “answering all the questions [the EMA] have asked and working very collaboratively with them and the same is true for the...
...It has no native vaccine business, focusing instead on R&D in such areas as oncology....
...His comments came after one of the largest studies into the prevalence of Covid-19 in England found the R rate — the average number of new cases generated by an infected individual — was 1.6....
...The government office for science estimated the R number in the UK was between 1.1 and 1.3, compared to 1.2 and 1.4 last week....
...On Sunday, Soriot’s friend José Baselga, AstraZeneca’s head of oncology R&D, died in Spain....
...Baroness Dido Harding, chair of NHS Test and Trace, defended the government’s record of testing and tracing on Tuesday, arguing that it was just one of the many methods being used to reduce the R number....
...CRUK has been responsible for taking 160 drugs into early clinical trials, and is a key part of an R&D infrastructure that, with further investment, can form part of “Brand UK” when the country leaves the...
International Edition